s6y

ID BIOMEDICAL CORP

CIK
889330
Industry
Biological Products, (No Diagnostic Substances)

Ownership 7

  1. SC 13G/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G Major Shareholders
  4. SC 13G/A Major Shareholders
  5. SC 13G/A Major Shareholders
  6. SC 13G/A Major Shareholders
  7. SC 13G Major Shareholders

Prospectus 4

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. RW Registration Withdrawal Request
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Other 133

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 40-F/A Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 133 other filings